negative effects of glp 1 drugs GLP-1 Medications Infographic Long-term Success of GLP-1s Hinges

J.KimJ.et al (2021)

Beyond the Injection: The Practical Power of an Oral Small Molecule Orforglipron is an investigational, once-daily small molecule (non-peptide) oral glucagon-like peptide-1 (GLP-1) receptor agonist

Kamrul-Hasan ABM, Hannan MA, Asaduzzaman M, Rahman MM, Alam MS, Amin MN, et al

As a skeptic, I am allergic to the word miracle, but when we look at the data for GLP receptor agonists, along with the innumerable before and after photos of successful weight loss transformations, we are forced to admit that we have moved from a realm of wishful thinking into one of potent pharmacology

Adverse events were mostly mild-to-moderate gastrointestinal symptoms, consistent with other incretin-based therapies